Sept 16 (Reuters) - Perrigo Company Plc, the
manufacturer of generic drugs and over the counter medicines
targeted by activist investor Starboard Value LP, is exploring a
sale of the royalties from its multiple sclerosis drug Tysabri,
people familiar with the matter said.
Read more
No comments:
Post a Comment